In a recent study published in the journal PLOS ONE, researchers conducted a systematic review and meta-analyzed data on the impact of coronavirus disease 2019 (COVID-19) on male reproductive hormones and semen variables to determine whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections had an adverse impact on male fertility.
Background
The etiological agent of the COVID-19 pandemic, SARS-CoV-2, is a β-coronavirus that infects human cells by binding to the angiotensin-converting enzyme-2 (ACE-2) receptor. The ACE-2 receptor is found in the lungs, kidneys, heart, and testes, making all these organs possible entry points for the virus.
The COVID-19 pandemic was responsible for over 700 million cases and more than 7 million deaths. However, although the virus is known to primarily infect the respiratory system, research indicates that it can also adversely impact other organ systems. Studies have also found that SARS-CoV-2 infections are more severe in males than in females. Furthermore, studies have found that many males who had been infected with the earlier SARS-CoV-1 had developed orchitis or inflammation of the testes.
However, the data on the impact of SARS-CoV-2 on male reproductive health has been limited. Although some studies have reported associations between COVID-19 and decreased testosterone levels and lower semen quality, some of the findings have been considered methodologically weak.
About the study
The present study aimed to comprehensively review recent studies examining the impact of COVID-19 on male fertility and conducted a meta-analysis by comparing semen quality variables and reproductive hormone levels between infected and uninfected men to understand the influence of SARS-CoV-2 on male fertility.
The researchers used the PECO, or Population, Exposure, Comparator, and Outcomes, model to select studies that examined male patients of reproductive age who had been exposed to SARS-CoV-2. The review included both prospective and retrospective studies as long as they included COVID-19-negative controls or contained pre- and post-COVID-19 pandemic health data for the same individual. Studies that were in vitro, focused on female patients, or lacking control groups were excluded.
For the studies included in the review, the outcomes consisted of measurements of conventional semen parameters such as sperm count, ejaculate volume, sperm concentration, morphology, motility, and viability of the sperm, as well as leukocyte levels in the seminal fluid. The outcomes also included the levels of the male reproductive hormones, including testosterone, estrogen, prolactin, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). The Measurements also included ratios of testosterone to LH and FSH to LH.
For the meta-analysis, the data extracted from the studies consisted of sample sizes, country of study, study design, the methods used to diagnose COVID-19, and key outcomes. The researchers used this data to calculate standardized mean differences, with extensive sensitivity analyses to avoid bias and assess sources of diversity. The parameters were also compared for changes before and after treatment for COVID-19.
Results
The review identified 40 eligible studies published from 12 different countries between 2020 and 2023 that examined the impact of SARS-CoV-2 on male reproductive health. The key findings from the meta-analysis covered the impact of COVID-19 on several aspects of male reproductive health.
The study found that COVID-19 was significantly associated with decreased ejaculate volume, with sensitivity analyses confirming consistent reductions in ejaculate volume after SARS-CoV-2 infections. However, the sensitivity analyses showed that the difference in ejaculate volume before and after COVID-19 treatment was not statistically significant, indicating that the impact of treatment may be limited. The sperm counts also decreased after SARS-CoV-2 infections, although the sensitivity analyses indicated that these reductions were marginal.
Individuals infected with SARS-CoV-2 also showed significantly lower sperm concentrations, and no changes were seen in sperm concentrations after treatment for COVID-19. This finding remained consistent even after accounting for potential study biases and diversity, reinforcing the robustness of the result. COVID-19 was also found to lower sperm viability and motility, with the difference in sperm viability remaining consistent even after the sensitivity analysis.
Comparisons between infected and uninfected individuals revealed no significant differences in sperm morphology. However, comparisons of sperm morphology in the same individual before and after SARS-CoV-2 infections revealed lower levels of morphologically normal sperm. The analysis showed that while the overall morphology differences between infected and uninfected individuals were not significant, the within-individual changes suggest that SARS-CoV-2 may have a subtle but noteworthy effect on sperm morphology.
The reproductive hormone levels were also significantly altered in COVID-19 patients, with elevated prolactin and marginally higher estrogen levels in infected men. Interestingly, the study found substantial variability in testosterone levels before and after treatment, suggesting that COVID-19’s impact on this hormone may be more complex than initially understood. However, the leukocyte levels in the seminal fluid were similar between infected and uninfected men.
Conclusions
To summarize, the study reviewed and conducted a meta-analysis of studies examining the impact of COVID-19 on male reproductive health and found that SARS-CoV-2 had a significant negative impact on male fertility, particularly on parameters such as ejaculate volume, viability, and motility of the sperm, and sperm concentration and count. Although the treatment of COVID-19 partially alleviated some of the affected parameters, the findings suggest that these improvements may not be sufficient to restore pre-infection levels, particularly for parameters like sperm concentration and motility. The study also highlighted the need for further research to fully understand the long-term effects of COVID-19 on male fertility and to explore potential therapeutic interventions.
- V. J., Ashonibare, P. J., Ashonibare, T. M., Akhigbe, & E, A. R. (2024). SARS-CoV-2 impairs male fertility by targeting semen quality and testosterone level: A systematic review and meta-analysis. PLOS ONE, 19(9), e0307396-. DOI:10.1371/journal.pone.0307396, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0307396

News
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]
AI matches doctors in mapping lung tumors for radiation therapy
In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy tissue. But this process, called [...]
Scientists Finally “See” Key Protein That Controls Inflammation
Researchers used advanced microscopy to uncover important protein structures. For the first time, two important protein structures in the human body are being visualized, thanks in part to cutting-edge technology at the University of [...]
AI tool detects 9 types of dementia from a single brain scan
Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single, widely available scan—a transformative [...]
Is plastic packaging putting more than just food on your plate?
New research reveals that common food packaging and utensils can shed microscopic plastics into our food, prompting urgent calls for stricter testing and updated regulations to protect public health. Beyond microplastics: The analysis intentionally [...]
Aging Spreads Through the Bloodstream
Summary: New research reveals that aging isn’t just a local cellular process—it can spread throughout the body via the bloodstream. A redox-sensitive protein called ReHMGB1, secreted by senescent cells, was found to trigger aging features [...]
AI and nanomedicine find rare biomarkers for prostrate cancer and atherosclerosis
Imagine a stadium packed with 75,000 fans, all wearing green and white jerseys—except one person in a solid green shirt. Finding that person would be tough. That's how hard it is for scientists to [...]
Are Pesticides Breeding the Next Pandemic? Experts Warn of Fungal Superbugs
Fungicides used in agriculture have been linked to an increase in resistance to antifungal drugs in both humans and animals. Fungal infections are on the rise, and two UC Davis infectious disease experts, Dr. George Thompson [...]